Safety and drug test for AUR107 in advanced cancers
Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This early-phase study tests whether AUR107 is safe and may help shrink or control advanced solid tumors that have come back or progressed. You may be considered if standard treatments no longer work and you meet specific blood, organ, and health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your cancer is a stage IV solid tumor that has measurable disease on scan
- You’ve tried standard curative treatments and then at least two prior cancer drug treatments in the metastatic stage
- Your body function tests are adequate: low infection-fighting cell count, low platelets, or low hemoglobin may disqualify you
- Your organs work well enough for the study (kidneys and liver blood tests meet limits)
- You can take and keep oral (swallowed) study medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental oral drug called AUR108 for people with advanced lymphoma that has come back after at least two prior treatments. The goal is to see if the drug is safe and if it can help shrink or control the lymphoma.
This trial tests a new oral medication called AUR112 for people with advanced lymphoma or CLL that has not responded to at least 2 prior treatments. The goal is to see if it is safe and how it works in the body.
This early study tests a new medicine (JAB-2485) in adults with advanced solid tumors (cancers that have spread or grown locally). You may join to see if it can shrink tumors or control the disease when other treatments haven’t worked or weren’t tolerated.
This trial tests an experimental drug called GEN1079 for people with advanced solid tumors that have spread or cannot be removed. The goal is to see if it's safe and if it helps shrink tumors.
This trial tests a new drug called AUR103 in patients with advanced neuroendocrine tumors (slow-growing cancers of hormone-producing cells) that have grown despite previous cancer treatment. The study aims to see if AUR103 can slow or stop tumor growth.
This early-phase trial tests a new drug called ASD141 for people with advanced solid tumors that no longer respond to standard treatments. The goal is to see if it is safe and how well it works against the cancer.
Hear when a new Relapsed Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.